Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > BNOEF BIONOMICS LTD > Key Indicators
BNOEF BIONOMICS LTD
0.0350.0000.00%
YOY
Do not show
Hide blank lines
(Q2)2021/12/31(FY)2021/06/30(Q4)2021/06/30(Q2)2020/12/31
Financial Ratios
Efficiency Ratios TTM
Receivable Turnover(T)
-- -- -- -- -- -- -37.86% 1.5893
Fixed Assets Turnover(T)
-- -- -- -- -- -- -92.77% 0.0498
Total Asset Rate(T)
-- -- -- -- -- -- -94.69% 0.0015
ROIC
-2127.01% -47.211% -14.57% -20.460% -14.57% -20.460% 123.67% 2.329%
ROE
-1221.05% -53.892% 36.59% -29.384% 36.59% -29.384% 88.14% -4.079%
ROA
-2714.09% -43.019% -26.98% -20.277% -26.98% -20.277% 83.02% -1.529%
Efficiency Ratios
ROE 5 Year Average
-- -- 5.99% -46.277% -- -- -- --
ROA 5 Year Average
-- -- 0.65% -18.571% -- -- -- --
Average 5 Years ROIC
-- -- 6.35% -23.212% -- -- -- --
Profitability Ratios TTM
Gross Margin
-- -- -- -- -- -- 0% 100.000%
Operating Margin
-- -- -- -- -- -- -2455.8% -19756.496%
Net Margin
-- -- -- -- -- -- -219.54% -1037.041%
EBITDA Margin
-- -- -- -- -- -- 1719.57% 35.3409%
R & D Expense Ratio
-- -- -- -- -- -- 2991.93% 7295.100%
Sales Expense Ratio
-- -- -- -- -- -- -- 0.000%
Administration Expense Rate
-- -- -- -- -- -- 1683.8% 9952.700%
Financial Health Ratios
Long-Term Debt to Equity Ratio
-92.79% 1.019% -97.06% 1.457% -97.06% 1.457% -68.88% 14.132%
Total Assets to Common Equity
-39.93% 112.542% -58.05% 114.005% -58.05% 114.005% -52.11% 187.360%
Debt to Asset Ratio
-97.89% 1.276% -98.11% 1.823% -98.11% 1.823% -50.51% 60.336%
Current Ratio
1730.9% 13.4589 1200.61% 13.1016 1200.61% 13.1016 -33.5% 0.7351
Quick Ratio
1870.74% 12.5159 2101.83% 12.3426 2101.83% 12.3426 14.04% 0.6351
GrowthRatios
Growth Ratios
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Bionomics Ltd. is a clinical stage biopharmaceutical company. It engages in the development of novel drug candidates focused on the treatment of serious central nervous system disorders. The company was founded in 1996 and is headquartered in Eastwood, Australia.
CEO: --
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...